Find PIRBUTEROL ACETATE manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 65652-44-0, Maxair, Pirbuterol acetate [usan], Spirolair, Pirbuterol monoacetate, Cp-24,314-14
Molecular Formula
C14H24N2O5
Molecular Weight
300.35  g/mol
InChI Key
QSXMZJGGEWYVCN-UHFFFAOYSA-N
FDA UNII
1EH73XKR9N

PIRBUTEROL ACETATE
Pirbuterol Acetate is the acetate salt form of pirbuterol, a synthetic catecholamine and a pyridine derivative with sympathomimetic and bronchodilatory effects. Pirbuterol acetate selectively stimulates beta-2 adrenergic receptors, resulting in initiation of intracellular adenylate cyclase activity leading to increased levels of cAMP. As a result muscle relaxation (broncho- and vasodilation) occurs via cAMP-dependent signal transduction. In addition, elevated levels of cAMP inhibit release of inflammatory mediators from mast cells.
1 2D Structure

PIRBUTEROL ACETATE

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
acetic acid;6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
2.1.2 InChI
InChI=1S/C12H20N2O3.C2H4O2/c1-12(2,3)13-6-11(17)8-4-5-10(16)9(7-15)14-8;1-2(3)4/h4-5,11,13,15-17H,6-7H2,1-3H3;1H3,(H,3,4)
2.1.3 InChI Key
QSXMZJGGEWYVCN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(=O)O.CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O
2.2 Other Identifiers
2.2.1 UNII
1EH73XKR9N
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino Ethyl)pyridine, Dihydrochloride

2. Cp 24315-1

3. Cp-24,314-1

4. Cp-24315-1

5. Maxair

6. Pirbuterol

7. Pirbuterol Acetate Salt

8. Pirbuterol Dihydrochloride

9. Pirbuterol Sulfate

10. Pyrbuterol

2.3.2 Depositor-Supplied Synonyms

1. 65652-44-0

2. Maxair

3. Pirbuterol Acetate [usan]

4. Spirolair

5. Pirbuterol Monoacetate

6. Cp-24,314-14

7. 1eh73xkr9n

8. 65652-44-0 (acetate)

9. 2-(hydroxymethyl)-6-(1-hydroxy-2-tert-butylamino-ethyl)-pyridin-3-ol

10. Cp 24314-14; Maxair;spirolair

11. Cp-24314-14

12. Pirbuterol Acetate (usan)

13. Acetic Acid;6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol

14. 6-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)pyridin-3-ol; Acetic Acid

15. Einecs 265-862-4

16. Unii-1eh73xkr9n

17. Maxair (tn)

18. Schembl3600

19. Alpha(sup 6)-((tert-butylamino)methyl)-3-hydroxy-2,6-pyridinedimethanol Monoacetate (salt)

20. Chebi:8246

21. Chembl1200444

22. Dtxsid40984214

23. Pirbuterol Acetate [vandf]

24. Pirbuterol Acetate [mart.]

25. Pirbuterol Monoacetate [mi]

26. Pirbuterol Acetate [who-dd]

27. Alpha6-((tert-butylamino)methyl)-3-hydroxypyridine-2,6-dimethanol Monoacetate

28. Pirbuterol Acetate [orange Book]

29. 2,6-pyridinedimethanol, Alpha(sup 6)-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, Monoacetate (salt)

30. D00686

31. Pirbuterol Acetate 100 Microg/ml In Acetonitrile

32. Pirbuterol Acetate, Vetranal(tm), Analytical Standard

33. Q27252326

34. Pirbuterol Acetate, United States Pharmacopeia (usp) Reference Standard

35. Acetic Acid--6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol (1/1)

36. .alpha.6-((tert-butylamino)methyl)-3-hydroxy-2,6-pyridinedimethanol Monoacetate (salt)

37. 2,6-pyridinedimethanol, .alpha.6-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, Acetate (1:1)

38. 2,6-pyridinedimethanol, .alpha.6-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, Monoacetate (salt)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 300.35 g/mol
Molecular Formula C14H24N2O5
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass300.16852187 g/mol
Monoisotopic Mass300.16852187 g/mol
Topological Polar Surface Area123 Ų
Heavy Atom Count21
Formal Charge0
Complexity261
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameMaxair
PubMed HealthPirbuterol (By breathing)
Drug ClassesBronchodilator
Drug LabelThe active component of MAXAIR AUTOHALER (pirbuterol acetate) is (R,S)6-{[(1,1-dimethylethyl)amino]methyl}-3-hydroxy-2,6-pyridinedimethanol monoacetate salt, a beta-2 adrenergic bronchodilator, having the following chemical structure:Pirbuterol ace...
Active IngredientPirbuterol acetate
Dosage FormAerosol, metered
RouteInhalation
Strengtheq 0.2mg base/inh
Market StatusPrescription
CompanyMedicis

2 of 2  
Drug NameMaxair
PubMed HealthPirbuterol (By breathing)
Drug ClassesBronchodilator
Drug LabelThe active component of MAXAIR AUTOHALER (pirbuterol acetate) is (R,S)6-{[(1,1-dimethylethyl)amino]methyl}-3-hydroxy-2,6-pyridinedimethanol monoacetate salt, a beta-2 adrenergic bronchodilator, having the following chemical structure:Pirbuterol ace...
Active IngredientPirbuterol acetate
Dosage FormAerosol, metered
RouteInhalation
Strengtheq 0.2mg base/inh
Market StatusPrescription
CompanyMedicis

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Bronchodilator Agents

Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)


Adrenergic beta-2 Receptor Agonists

Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)


Cardiotonic Agents

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)


REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

USP

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty